Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases
Mitochondrial transplantation (MTx) offers a promising therapeutic avenue for mitochondrial diseases. This review comprehensively evaluates MTx, differentiating its feasibility for mtDNA‐ and nDNA‐based disorders. It examines its potential for genetic correction, alongside inherent limitations, technical challenges, and crucial ethical considerations ...
Parmeshar Singh +17 more
wiley +1 more source
IUTF Dataset: Enabling Cross-Border Resource for Analysing the Impact of Rainfall on Urban Transportation. [PDF]
Lin X +6 more
europepmc +1 more source
How to harmonise public and private datasets for mapping and monitoring soil carbon dynamics
Maria Fantappiè, Roberta Farina
openalex +1 more source
This study employs digital advanced manufacturing to develop lightweight, compact porous distributors as alternatives to conventional bipolar plates in PEM fuel cells. A graphene‐coated nickel foam achieves a power density of 1.52 W cm−2, while titanium‐based designs deliver lightweight solutions: an LPBF‐fabricated Gyroid lattice reaches 1.36 W cm−2 ...
Hadi Heidary +9 more
wiley +1 more source
The role of MedDRA in global pharmacovigilance and public health during COVID-19: pandemic preparedness and response. [PDF]
O'Hare B, Ibrahim H, Revelle P.
europepmc +1 more source
From Materials to Systems: Challenges and Solutions for Fast‐Charge/Discharge Na‐Ion Batteries
This review systematically analyzes the key characteristics limiting the fast‐charge/discharge capability of Na‐ion batteries (SIBs) from a multi‐scale perspective encompassing electrode materials, the electrode‐electrolyte interface, and the system. Furthermore, it presents practical solution strategies for the fundamental issues arising at each scale,
Bonyoung Ku +5 more
wiley +1 more source
Letter to the Editor Re: Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06: Clinical validation of the VENTANA PATHWAY anti-HER2/neu (4B5) assay in HER2-low and HER2-ultralow breast cancer. [PDF]
Horimoto Y.
europepmc +1 more source
Proceedings of interactive meet on harmonisation of drug proving programme
RajK Manchanda +2 more
openalex +2 more sources

